The 7th Supply Chain & Logistics for Cell & Gene Therapies Summit is the only industry-led forum exclusively dedicated to advancing supply chain and logistics strategies for advanced therapies, at a time when the sector faces unprecedented operational complexity. As rising tariffs, evolving regulations, and capacity constraints continue to challenge global networks, the need to scale these therapies reliably and efficiently has never been greater. This summit arrives at a critical time for supply chain, logistics, and operations leaders across pharma and biotech.

Across two focused conference days and an interactive workshop day, the summit delivers practical, case-based insights into building resilient, scalable, and digitally grounded supply chains. The program spans the full end-to-end journey, from apheresis through clinical sites to commercial distribution, covering digital visibility, regulatory navigation, cost of goods, cross-functional collaboration and next-generation manufacturing models. Attendees will benchmark what is working in real-world supply environments, learn directly from experienced industry leaders including Bristol Myers Squibb, AstraZeneca, Johnson & Johnson, Abeona Therapeutics, ProKidney and Sana Biotechnology, and explore how to scale without compromising patient safety or product integrity.

Designed by and for the industry, this year’s summit will equip supply chain leaders with the strategies, practical frameworks, and peer insights needed to reliably scale life-changing therapies, mitigate risk across shifting global networks and support clinical and commercial readiness.

Look forward to:

• 75+ Leading supply chain and logistics experts from pharma, biotech, and clinical sites
• End-to-end coverage from clinic to commercialization, with practical insights into effective scale-up, cost management, and digital transformation 
• Targeted networking with decision-makers through expert panels, roundtables, and structured sessions 
• Case-study driven presentations across modalities and stages, from early clinical supply to commercial operations 

Don’t just take our word for it, see what your peers had to say: 

Sherry Kallingal, Senior Director, Operational Excellence, ProKidney

“This is the one conference I would not miss. It's the only place where you can have deep, nuanced discussions specific to cell and gene therapy supply chains - the complexities of COI/COC implementation, autologous patient logistics, phase-appropriate digital systems, and regulatory challenges that are unique to our industry. Last year's conversations on ISBT traceability, commercial transition planning, and supplier qualification were very insightful. I'm looking forward to 2026 to share our lessons learned and collaborate with the peers who truly understand the operational realities of scaling CGT supply chains.

Sherry Kallingal, Senior Director, Operational Excellence, ProKidney

Reducing complexity in supply chain and logistics is important now because our systems, therapies, and expectations have evolved - but many of our operational processes have not. Reducing complexity is no longer optional; it’s essential to delivering safe, high‑quality, reliable care in a resource‑constrained, fast‑moving clinical environment.

Find the full registration details here.